⾹港⼤學理學院化學系李學臣教授的研究團隊歷時⼗年研發的抗⽣素新藥 ——咔喏霉素 （Kynomycin），剛獲得國家藥品監督管理局核准簽發《藥物臨床試驗批准通知書》，同意開展作臨床試驗。咔喏霉素是具有全新化學結構的環脂肽類 1 類化學新藥，主要針對細菌導致的複雜性⽪膚及軟組 織感染。
New Antibiotic Drug Developed by HKU Chemistry Research Team Approved for Clinical Trials in Humans
港⼤團隊開發雙重特洛伊⽊⾺⾦屬-鐵霉素複合物 為對抗细菌耐藥性提供新思路
HKU Scientists Pioneer Dual Trojan Horse Approach to Combat Superbugs
Academic staff dedicates to arrest dental caries.
A service providing free dental health checks in local kindergartens seeks to solve the common problem of tooth decay among young children in Hong Kon
古藥新⽤：⼆千年歷史抗菌藥硝酸銀 與「最後防線抗⽣素」粘菌素組合 可對抗耐藥性超級細菌e-sensitise the last-line Antimicrobial Colistin against superbugs
Re-sensitise the last-line Antimicrobial Colistin against superbugs
Abstract Deadline: Jul 30, 2019; Discounted Registration Deadline: Aug 14, 2019; To encourage participation of HKU staff and RPg students, sponsorship...
Miss Cora CHAN Sau Wai, Department of Law Dr Esther CHAN Wai Yin, Department of Pharmacology and Pharmacy Dr GU Weixia, Department of Law Dr HUANG...
The research team led by Dr Chen Jianping, Associate Professor of School of Chinese Medicine, Li Ka Shing Faculty of Medicine, HKU develops a...
A recent clinical study conducted by the School of Chinese Medicine, Li Ka Shing Faculty of Medicine, HKU in collaboration with Yan Chai Hospital...
Being culturally sensitive and holistically oriented, the programme is tailored for healthcare and social service professionals who aspire to develop...
